Werewolf Therapeutics, Inc. (HOWL)

NASDAQ: HOWL · Real-Time Price · USD

0.5151

-0.0275 (-5.07%)

At close: May 15, 2026, 4:00 PM EDT

0.5199

+0.0048 (0.93%)

Pre-market: May 18, 2026, 7:00 AM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Discovery and Development of Cancer Therapeutics	1.89M	19.94M	16.40M	-
Discovery and Development of Cancer Therapeutics Growth	-90.55%	21.60%	-	-
Total	1.89M	19.94M	16.40M	-
Total Growth	-90.55%	21.60%	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States	1.89M	19.94M	16.40M	-
United States Growth	-90.55%	21.60%	-	-
Total	1.89M	19.94M	16.40M	-
Total Growth	-90.55%	21.60%	-	-

Source: S&P Global Market Intelligence.